# Therapeutic Effect of Methalazine on 27 Cases of Suppurative Hidradenitis

> **NCT06568224** · — · COMPLETED · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 27 (actual)

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** Mesalazine

## Key facts

- **NCT ID:** NCT06568224
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-01
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2024-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06568224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06568224, "Therapeutic Effect of Methalazine on 27 Cases of Suppurative Hidradenitis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06568224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*